Skip to content

Choline uptake study

Choline uptake study - CUP-Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46199
Enrollment
18
Registered
2018-12-07
Start date
2019-02-05
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

opname van een voedingsmiddel bioavailability uptake

Interventions

Study participants will receive a test drink with phospholipid-bound choline, and a control drink with choline added as a salt.

Sponsors

AAK Netherlands BV
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Apparently healthy men and women * Age between 30 and 70 years * Body mass index (BMI) between 18.5 and 24.9 kg/m2 * Having veins suitable for blood sampling via a catheter (judged by study nurse/ medical doctor)

Exclusion criteria

Exclusion criteria: * Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease) * History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints * History of liver dysfunction (cirrhosis, hepatitis) or liver surgery * Kidney dysfunction (self-reported) * Use of medication that may influence the study results, such as laxatives, stomach protectors and drugs that can affect intestinal motility * Use of fishoil or choline supplements * Reported slimming, medically prescribed or vegan diet * Current smokers * Alcohol intake *4 glasses of alcoholic beverages per day * Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported) * Abuse of illicit drugs * Food allergies for products that we use in the study * Participation in another clinical trial at the same time * Being an employee of the department Consumer Science & Health group of Wageningen Food & Biobased Research

Design outcomes

Primary

MeasureTime frame
The main study parameter is plasma choline, betaine and dimethylglycine measured before and after consumption of a choline drink.

Secondary

MeasureTime frame
The secondary study parameter is plasma DHA concentrations.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)